SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Pepek Philippe is a whimsical meme coin inspired by the lavish lifestyle of billionaire frogs flaunting luxury watches. This project humorously showcases the world of amphibious elites who enjoy opulence, fine dining, private jets, beautiful women, fast cars, mansions, and, of course, top-tier timepieces. The coin celebrates this absurdly rich lifestyle, blending humor with luxury culture to create a fun, engaging crypto experience.

Pepek Philippe

Pepek Philippe ($PEPEK) is trending amid high volatility, with some users promoting it as the next meme legend while others warn of potential scams and rug pulls. Community discussions revolve around quick gains, 'diamond hands,' and availability on Phantom Wallet. Some users are drawing comparisons to other meme coins and urging caution due to the risks associated with new and unproven cryptocurrencies.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending amid community discussions about potential meme coin opportunities and projects building within its ecosystem, such as $UPDOG and $CAW. Some traders are speculating on short-term price movements and potential ETF approvals, while others are evaluating its performance relative to other cryptocurrencies like $ETH and $BTC. Community sentiment is mixed, with some expressing bullish views and others highlighting potential risks and volatility.

mF International Ltd. is a holding company, which engages in the development and provision of financial trading solutions through its subsidiary. It offers real-time mission critical forex, bullion and commodities trading platform solutions, financial value-added services, mobile applications, and financial information for brokers and institutional clients via internet or platform as software as a service. The company was founded by Tai Wai Lam and Chi Weng Tam on June 15, 2022, and is headquartered in Hong Kong.

mF International Ltd - Ordinary Shares - Class A

mF International Ltd

mF International (MFI) is trending due to a recent filing for a mixed shelf offering of up to $700 million, sparking excitement about potential future moves. The community is drawing comparisons to other low-float stocks that have experienced significant gains, like $QMMM and $HKD, while noting MFI's connection to the crypto space and potential for a squeeze.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media is trending amid discussions around protests and political ideologies, with community members debating the role and impact of various political figures. The commentary includes discussion of POTUS candidates, and election outcomes. Some users are referencing past controversies and legal situations related to figures associated with the company.

SU Group Holdings Ltd. engages in the provision of security-related engineering services, and security guarding and screening services. It operates through the Security-Related Engineering Services and Security Guarding and Screening Services segments. The company was founded by Ming Chan in 1998 and is headquartered in Hong Kong.

SU Group Holdings Ltd. - Ordinary Shares - Class A

SU Group Holdings Ltd.

SUGP is trending due to renewed NASDAQ compliance and a recently announced, record-breaking hospital contract, prompting speculation about a potential short squeeze. Traders are comparing it to other Hong Kong-based stocks that have experienced significant gains, pointing to the low float and high cost to borrow as contributing factors. The community is actively watching for a potential breakout.

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Humana Inc.

Humana Inc

Humana is trending amid community discussion around potential partnerships, particularly a speculated deal involving Clover Health's AI platform, which could lead to a significant re-rate. Bullish investors cite upcoming catalysts such as Medicare Advantage quality ratings, analyst upgrades, and reaffirms 2026 growth, while others express concerns over market manipulation and recent price volatility within the healthcare sector.

Royal Caribbean Group is a cruise company, which engages in the ownership and operation of the following global cruise brands: Royal Caribbean International, Celebrity Cruises, and Silversea Cruises. The firm also holds interest in TUI Cruises GmbH, which operates the German brands TUI Cruises and Hapag-Lloyd Cruises. The company was founded by Arne Wilhelmsen in 1968 and is headquartered in Miami, FL.

Royal Caribbean Group

RCL is trending amid discussions about its potential and valuation, with some analysts setting optimistic price targets. Community members are debating whether the stock is overbought after a significant run-up, while others highlight strong bookings and growth in the travel sector. Some are comparing RCL to peers like CCL and NCLH, considering factors like debt and growth strategies.

Helium is a decentralized machine network powered by a physical blockchain. The network is created by gateways who also double as miners on our network. These gateway operators can earn tokens based on coverage they provide as well as transaction fees gained from machines connecting to their gateway  Helium is a new cryptocurrency. Hotspots earn for providing and validating wireless coverage and when devices on the network connect to the internet through Hospots  Helium is mined and distributed to Hotspot Owners, Helium Inc, and investors. There is no pre-mine of Helium, and every month approximately 5,000,000 new Helium are minted.  At the end of each mining period, roughly every 30 to 60 mins, Helium is distributed according to the allocation shown:

Helium

Helium ($HNT) is trending amid community discussions about its utility, potential for price movement, and the impact of Helium Mobile's network. Some community members express concerns over tokenomics, while others remain optimistic about future growth and potential listings. Technical analysis and broader market conditions also contribute to the current conversations around Helium.

LTC Properties, Inc. is a real estate investment trust, which engages in managing seniors housing and health care properties. It operates through the Texas, Michigan, Florida, Wisconsin, Colorado, and Remaining States geographic segments. The company was founded by Andre C. Dimitriadis on May 12, 1992 and is headquartered in Westlake Village, CA.

LTC Properties, Inc.

LTC Properties is trending due to recent analyst ratings adjustments and discussions around its dividend yield. The community is actively analyzing options strategies and LEAPS contracts related to the stock. Some also mention the healthcare REIT's resilience in an interest rate-sensitive environment.

Emerson Electric Co. is a global technology and software company, which engages in the provision of solutions. It operates through the following segments: Final Control, Measurement and Analytical, Discrete Automation, Safety and Productivity, Intelligent Devices, and Software and Control. The Final Control segment focuses on providing control, isolation, shutoff, pressure relief, pressure safety valves, actuators, and regulators for process and hybrid industries. The Measurement and Analytical segment involves the instrumentation measuring the physical properties of liquids, gases, pressure, temperature, level, flow, acoustics, corrosion, pH, conductivity, water quality, toxic gases, and flame. The Discrete Automation segment includes solenoid, pneumatic, valve position indicators, pneumatic cylinders and actuators, air preparation equipment, pressure and temperature switches, electric linear motion solutions, programmable automation control systems and software, electrical distribution equipment, and materials joining solutions. The Safety and Productivity segment consists of pipe-working tools: pipe wrenches, pipe cutters, pipe threading and roll grooving equipment, battery hydraulic tools for press connections, drain cleaners, tubing tools and diagnostic systems, including sewer inspection cameras and locating equipment. The Software and Control segment processes by collecting and analyzing information from measurement devices in the plant and using that information to adjust valves, pumps, motors, drives, and other control hardware. The company was founded by Charles Meston and Alexander Meston on September 24, 1890, and is headquartered in St. Louis, MO.

Emerson Electric Co.

Emerson Electric is trending due to heightened options activity and target price increases from analysts, with community discussion focused on its potential for growth in automation. The stock's trading volume and recent collaborations, like the one with PETRONAS, are also capturing investor attention. As a dividend king with exposure to industrial automation and digital transformation, EMR remains a steady holding for long-term investors.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Vivani Medical, Inc. (VANI), on Wednesday, <a target="_blank" rel="noopener noreferrer nofollow" href="https://investors.vivani.com/investors/news-events/press-releases/detail/188/vivani-medical-announces-positive-preclinical-weight-loss">announced</a> promising preclinical data for its semaglutide implant in development for weight management in overweight patients.NPM-139 is a small, subdermal semaglutide implant. Semaglutide is the active ingredient in popular weight-loss drugs such as Ozempic or Wegovy.Vivani Medical CEO Adam Mendelsohn said products containing semaglutide generated $25 billion in 2024, and demand for these products continues to soar.“Since over half of these patients regularly miss doses as indicated by real-world medication adherence data, we believe that there is a tremendous opportunity for a more convenient delivery option that will eliminate missed doses and thereby improve real-world health outcomes,” he said.The company said on Wednesday that a single administration of the implant in healthy rats resulted in 20% lower body weight through a 91-day treatment period as compared to a control group that received a sham implant.NPM-139 is being initially developed as a twice-yearly implant but has the potential benefit of once-yearly administration, the company said.The company also said it recently successfully implanted an initial group of human subjects with NPM-115, a miniature, ultra long-acting exenatide implant aimed at overweight persons.Data from the study of NPM-115 is expected to be available mid-2025. The study is also expected to pave the way for the development of NPM-139, the company said.On Stocktwits, retail sentiment about Vivani rose from ‘bullish’ to ‘extremely bullish’ territory while message volume jumped from ‘low’ to ‘high’ in the past 24 hours.<figure class="image"><img style="aspect-ratio:649/150;" src="https://news.stocktwits-cdn.com/Screenshot_2025_03_26_at_1_56_56_PM_png_deb5769989.webp" alt="VANI's Sentiment Meter and Message Volume as of 1:55 p.m. ET on March 26, 2025 | Source: Stocktwits" width="649" height="150"><figcaption>VANI's Sentiment Meter and Message Volume as of 1:55 p.m. ET on March 26, 2025 | Source: Stocktwits</figcaption></figure> A Stocktwits commended the company’s idea of implants, taking out the need for daily pills or injections.<stembedurl>https://stocktwits.com/ZabDad/message/609254484</stembedurl>Brokerage H.C. Wainwright said on Wednesday that the preclinical data validates the versatility of the company’s proprietary NanoPortal implant technology while reiterating a ‘Buy’ rating on the shares with a price target of $4.A Stocktwits user, however, highlighted the company’s low cash. As of Sept. 30, 2024, Vivani had cash, cash equivalents, and restricted cash totaling $21 million.<stembedurl>https://stocktwits.com/Earl40/message/609298832</stembedurl><a href="https://stocktwits.com/symbol/VANI">VANI shares</a> traded nearly 2% higher on Wednesday afternoon. The stock is down over 6% this year and by over 40% in the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/rivian-spins-off-micromobility-business-into-new-company-also/chJbT8iRb3m">Rivian Spins Off Micromobility Business Into New Company ‘Also’: Retail’s Elated</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A tape measure lies on a scale while a young woman buries her head in her hands in the background. (Photo by Pia Bayer/picture alliance via Getty Images)

Vivani Medical Announces Promising Preclinical Weight Loss Data For Its Semaglutide Implant: Retail Sentiment Soars

The company said on Wednesday that a single administration of the implant in healthy rats resulted in 20% lower body weight through a 91-day treatment period as compared to a control group that received a sham implant. 

Equity

Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast

Vivani Medical, Inc. (NASDAQ: VANI) (the Company or Vivani), an innovative biopharmaceutical company developing miniaturized, ultra long-acting drug implants, announced today that CEO Adam...

Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results

Vivani Medical, Inc. (Nasdaq: VANI) (Vivani or the Company), a biopharmaceutical company developing miniaturized, long-acting drug implants, today reported financial results for the third quarter...

Vivani Medical to Present at the Partnership Opportunities in Drug Delivery (PODD) Event and ThinkEquity Conference in October 2024

Vivani Medical, Inc. (NASDAQ: VANI) (the Company or Vivani), an innovative biopharmaceutical company developing miniaturized, ultra long-acting drug implants, announced today that it will present at...

Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia

Vivani Medical, Inc. (Nasdaq: VANI) (Vivani or the Company), an innovative, biopharmaceutical company developing novel, ultra long-acting drug implants, today announced that the Bellberry Human...

EXCLUSIVE: Vivani Medical Advances Its Obesity Treatment Implant With New Clinical Trial in Australia

Vivani Medical receives approval for the first human trial of its GLP-1 obesity implant in Australia. The LIBERATE-1 trial will assess safety, tolerability, and weight loss outcomes, with data...

Vivani Medical to Present at the Emerging Growth Conference on September 25, 2024

Vivani Medical Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 Implant

Vivani Medical, Inc. (Nasdaq: VANI) (Vivani or the Company), an innovative biopharmaceutical company developing miniature, ultra long-acting, subdermal drug implants, today reported positive...

EXCLUSIVE: Vivani Medical Reveals Positive Preclinical Liver Fat Results From Miniature GLP-1 Implant For Obesity

Vivani Medical reports promising preclinical liver fat reduction results with its exenatide implant for obesity, showing potential as a differentiated treatment option. The LIBERATE-1 clinical trial...

Vivani Medical to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Vivani Medical, Inc. (Nasdaq: VANI) (Vivani or the Company), an innovative biopharmaceutical company developing miniature, ultra long-acting, subdermal drug implants, today announced its plans to...

Vivani Medical, Inc. is a preclinical stage biopharmaceutical company, which engages in the business of developing miniaturized, subdermal implants utilizing proprietary NanoPortal technology to enable long-term, near constant-rate delivery of a broad range of medicines to treat chronic diseases. It operates under the Biopharm Division and Neuromodulation Division segments. The company was founded by Adam Mendelsohn on May 22, 2003 and is headquartered in Alameda, CA.

Vivani Medical Inc

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

VANI
Vivani Medical Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest VANI News

VANIVivani Medical Inc